{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:09:07Z","timestamp":1792112947118,"version":"4.4.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T00:00:00Z","timestamp":1553817600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T00:00:00Z","timestamp":1553817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["1U01DK100928-01"],"award-info":[{"award-number":["1U01DK100928-01"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s10620-019-05591-w","type":"journal-article","created":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T08:02:23Z","timestamp":1553846543000},"page":"2645-2652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Importance of Hepatitis C Virus RNA Testing in Patients with Suspected Drug-Induced Liver Injury"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1384-2349","authenticated-orcid":false,"given":"Jawad","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Rajender","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans L.","family":"Tillmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H.","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naga","family":"Chalasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor J.","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Stolz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiman","family":"Barnhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin A.","family":"Cloherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay H.","family":"Hoofnagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,29]]},"reference":[{"key":"5591_CR1","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","volume":"148","author":"N Chalasani","year":"2015","unstructured":"Chalasani N, Bonkovsky HL, Fontana R, et al. United States drug induced liver injury network. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015;148:1340\u20131352.","journal-title":"Gastroenterology"},{"key":"5591_CR2","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/hep.27978","volume":"62","author":"BR Edlin","year":"2015","unstructured":"Edlin BR, Eckhardt BJ, Shu MA, et al. Toward a more accurate estimate of the prevalence of hepatitis C in the United States. Hepatology. 2015;62:1353\u20131363.","journal-title":"Hepatology"},{"key":"5591_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","volume":"108","author":"JE Zibbell","year":"2018","unstructured":"Zibbell JE, Asher AK, Patel RC, et al. Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004\u20132014. Am J Public Health. 2018;108:175\u2013181.","journal-title":"Am J Public Health"},{"key":"5591_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/hep.27800","volume":"62","author":"RI Hatia","year":"2015","unstructured":"Hatia RI, Dimitrova Z, Skums P, et al. Nosocomial hepatitis C virus transmission from tampering with injectable anesthetic opioids. Hepatology. 2015;62:101\u2013110.","journal-title":"Hepatology"},{"key":"5591_CR5","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/jmv.24588","volume":"89","author":"M Dirchwolf","year":"2017","unstructured":"Dirchwolf M, Marciano S, Mauro E, et al. Clinical epidemiology of acute hepatitis C in South America. J Med Virol. 2017;89:276\u2013283.","journal-title":"J Med Virol"},{"key":"5591_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jhin.2016.07.021","volume":"94","author":"S Senatore","year":"2016","unstructured":"Senatore S, Galli C, Conti A, et al. Hepatitis C virus outbreak in a haemodialysis unit: learning from failures. J Hosp Infect. 2016;94:249\u2013252.","journal-title":"J Hosp Infect"},{"key":"5591_CR7","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1186\/s12864-017-4269-2","volume":"18","author":"J Lara","year":"2017","unstructured":"Lara J, Teka M, Khudyakov Y. Identification of recent cases of hepatitis C virus infection using physical-chemical properties of hypervariable region 1 and a radial basis function neural network classifier. BMC Genom. 2017;18:880.","journal-title":"BMC Genom"},{"key":"5591_CR8","unstructured":"Astrakhantseva IV, Campo DS, Araujo A, et al. Differences in variability of hypervariable region 1 of hepatitis C virus (HCV) between acute and chronic stages of HCV infection. Silico Biol. 2011\u20132012;11:163\u201373."},{"key":"5591_CR9","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.3851\/IMP2471","volume":"17","author":"E Sagnelli","year":"2012","unstructured":"Sagnelli E, Tonziello G, Pisaturo M, et al. Clinical applications of antibody avidity and immunoglobulin M testing in acute HCV infection. Antivir Ther. 2012;17:1453\u20131458.","journal-title":"Antivir Ther"},{"key":"5591_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2165\/00002018-200932010-00005","volume":"32","author":"RJ Fontana","year":"2009","unstructured":"Fontana RJ, Watkins PB, Bonkovsky HL, et al. Drug-induced liver injury network (DILIN) prospective study: rationale, design and conduct. Drug Saf. 2009;32:55\u201368.","journal-title":"Drug Saf"},{"key":"5591_CR11","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/0895-4356(93)90102-7","volume":"46","author":"C Benichou","year":"1993","unstructured":"Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs\u2014II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol. 1993;46:1331\u20131336.","journal-title":"J Clin Epidemiol"},{"key":"5591_CR12","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1002\/hep.23577","volume":"51","author":"DC Rockey","year":"2010","unstructured":"Rockey DC, Seeff LB, Rochon J, et al. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology. 2010;51:2117\u20132126.","journal-title":"Hepatology"},{"key":"5591_CR13","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1053\/j.gastro.2011.07.051","volume":"141","author":"TJ Davern","year":"2011","unstructured":"Davern TJ, Chalasani N, Fontana RJ, et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology. 2011;141:1665\u20131672.","journal-title":"Gastroenterology"},{"key":"5591_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1053\/j.gastro.2014.03.045","volume":"147","author":"RJ Fontana","year":"2014","unstructured":"Fontana RJ, Hayashi PH, Gu J, et al. Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6\u00a0months from onset. Gastroenterology. 2014;147:96\u2013108.","journal-title":"Gastroenterology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05591-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-019-05591-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05591-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T14:21:07Z","timestamp":1589725267000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-019-05591-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,29]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["5591"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-05591-w","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,29]]},"assertion":[{"value":"14 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"JA, PHH, AS, VN, HB, JHH: No conflict of interest to disclose. KRR: Scientific Advisory Board-Merck, Abbvie, Gilead, Shionogi, Dova. Research Support (paid to the University of Pennsylvania) Abbvie, Gilead, Merck, Conatus, Intercept, Mallinckrodt. HLT: Abbott stocks from previous employment of Spouse, AbbVie Stocks and employment of spouse, Gilead Stocks, Novartis (DSMB). NC: Consultant for Abbvie, Lilly, Afimmune, NuSirt, Shire, Axovant, Madrigal, Allergan, Immuron and research support from Cumberland, Galectin, Lilly, and Exact Sciences. RJF: Research support from Gilead, BristolMyersSquibb, and Abbvie. Consulted for Alnylam Pharmaceuticals. GAC: Employee and Share Holder or Abbott Laboratories.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}